More about

Weight Loss

News
June 25, 2023
4 min read
Save

Combined GLP-1/amylin analog bests monotherapy for HbA1c drop, weight loss in diabetes

Combined GLP-1/amylin analog bests monotherapy for HbA1c drop, weight loss in diabetes

SAN DIEGO — Combination cagrilintide and semaglutide therapy is associated with a 15.6% weight loss and 2.2% reduction in HbA1c among adults with obesity and type 2 diabetes, according to a speaker.

News
June 24, 2023
6 min read
Save

SURMOUNT-2: Tirzepatide confers about 15% weight loss in adults with obesity and diabetes

SURMOUNT-2: Tirzepatide confers about 15% weight loss in adults with obesity and diabetes

SAN DIEGO — Adults with obesity and type 2 diabetes achieved a 14.7% weight loss at 72 weeks with 15 mg tirzepatide, according to data from the SURMOUNT-2 trial presented at the American Diabetes Association Scientific Sessions.

News
June 24, 2023
3 min read
Save

Oral GLP-1 confers up to 14.7% weight loss at 36 weeks for adults with obesity

Oral GLP-1 confers up to 14.7% weight loss at 36 weeks for adults with obesity

SAN DIEGO — Adults with obesity and without diabetes receiving the oral GLP-1 receptor agonist orforglipron lost 8.6% to 12.6% of their body weight at 26 weeks, according to a data from a phase 2 trial.

News
June 22, 2023
3 min read
Save

How losing weight can impact mental health

How losing weight can impact mental health

Obesity can have a significant impact on mental health.

News
June 20, 2023
1 min read
Save

Preoperative weight loss may not affect outcomes for patients with obesity undergoing TKA

Preoperative weight loss may not affect outcomes for patients with obesity undergoing TKA

Results published in the Journal of Arthroplasty showed patients with class II and class III obesity do not benefit or harm from preoperative weight loss prior to total knee arthroplasty.

News
June 01, 2023
2 min read
Save

Semaglutide linked to significant weight loss in adults with obesity in real-world study

Semaglutide linked to significant weight loss in adults with obesity in real-world study

Adults with overweight or obesity receiving semaglutide lost 13.4% of their body weight at 1 year, according to findings from a real-world study presented at the European Congress on Obesity.

News
May 26, 2023
3 min read
Save

Women with PCOS more likely to have perception of overweight, attempt weight loss

Women with PCOS more likely to have perception of overweight, attempt weight loss

Women with polycystic ovary syndrome are more likely to attempt to lose weight multiple times and perceive themselves as having overweight compared with women without PCOS, according to a study published in Obesity.

News
May 25, 2023
4 min read
Save

Telephone-based intervention helps women with breast cancer lose weight

Telephone-based intervention helps women with breast cancer lose weight

Women with breast cancer whose BMI fell in the overweight or obese ranges achieved meaningful weight loss via a telephone-based intervention, according to phase 3 study results.

News
May 25, 2023
3 min read
Save

Inability to control hunger in adolescents with obesity linked to body insecurity

Inability to control hunger in adolescents with obesity linked to body insecurity

Adolescents with obesity whose inability to control their hunger is a barrier to weight loss have a more negative perception about their body than adolescents who say inability to control hunger is not a barrier, according to a speaker.

News
May 24, 2023
1 min read
Save

Top in endocrinology: Novel weight loss drug; denosumab vs. alendronate for osteoporosis

Top in endocrinology: Novel weight loss drug; denosumab vs. alendronate for osteoporosis

Adults with overweight or obesity, but not type 2 diabetes, lost 14.9% of their body weight after 46 weeks of receiving BI 456906, a novel glucagon/GLP-1 receptor agonist, during a phase 2 clinical trial, according to a press release.

View more